PROFESSIONAL EDITION

The largest community of pharma leaders

Editor´s Pick

      First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life

      BETHESDA, Md.--(BUSINESS WIRE)--Today, the Cystic Fibrosis Foundation announced the initiation of the HERO-2: Home Reported Outcomes Study, a first-of-its-kind, at-home observational study that aims...

      Merck and Sanofi’s First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States

      KENILWORTH, N.J. & BRIDGEWATER, N.J.--(BUSINESS WIRE)--VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed as...

      Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

      CAMBRIDGE, Mass. & FARGO, N.D.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider...

      Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s COVID-19 Vaccine

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Ministry of Health, Labour...

      Recent Articles